Michigan Medicine Laboratories will be exhibiting at USCAP this month. The 11th annual meeting runs from March 19-24, 2022 in Los Angeles, CA. Be sure to stop by booth 633 and grab a go blue football!
Leadership is not about titles, positions, or flowcharts. It is about one life influencing another,” John Maxwell.
In early 2020, the truth of this statement came to life in the Department of Pathology. Our country, our world, was faced with a pandemic caused by a novel virus for which no hard and fast answers were to be had. In the face of constantly changing “facts,” leadership in Pathology was found at all levels. It began with the Chair, Dr. Charles Parkos.
The West Ann Arbor Blood Draw center located at 380 Parkland Plaza, Suite 130, Ann Arbor, MI 48103 will be closing early at 5:00pm on Wednesday, February 2nd and Thursday, February 3rd. For more information about the blood draw site, please visit West Ann Arbor Health Center | MLabs (umich.edu)
MLabs now offers new approved therapy with KEYTRUDA through the PD-L1 (22C3 Assay). KEYTRUDA is a medicine that may treat certain cancers by working with your immune system. This FDA approved companion diagnostic for KEYTRUDA to evaluate triple-negative breast cancer patients.
Michigan Medicine Laboratories, the reference laboratory division of Michigan Medicine, continues to serve the community with flexible options for fast, high-quality COVID-19 testing, including a convenient new testing location.
The North Carolina Society of Pathologist (NCSP) is having their annual 2021 meeting virtually this year. With this year's focus on pulmonary pathology, Dr. Jeffrey Myers was invited to be the key note speaker.
Join us in recognizing patient safety awareness week by reviewing our critical values policy. Download our flyer that shows the importance of critical values and how they can affect the lives of patients. And finally, if you are a client and looking for an instructional video for the critical values survey, please find that video link below.
U-M was recently ranked No. 9 among institutions globally in cancer research, according to the U.S. News & World Report 2021 Best Global University Rankings.
The detection of DDIT3 rearrangements can be useful in diagnosing myxoid liposarcoma – including uncommon histologic variants – and in distinguishing this sarcoma from other mesenchymal tumors that may be considered in the differential diagnosis.
Michigan Medicine named The Best and Brightest Companies to Work For®. A competition that identifies and honors organizations that display a commitment to excellence in their human resource practices and employee enrichment.